Indoleamine 2,3-dioxygenase expression in patients with allergic rhinitis: a case-control study

Area of Science:

• Immunology
• Allergy Research
• Enzymology

Background:

• Indoleamine 2,3-dioxygenase (IDO) is an enzyme that catalyzes tryptophan.
• IDO's role in lower airway allergic inflammation is suggested, but its function in allergic rhinitis remains uninvestigated.

Purpose of the Study:

• To assess IDO expression in the nasal mucosa of patients with allergic rhinitis.
• To compare IDO expression in birch pollen-allergic individuals during peak allergen exposure with non-atopic controls.

Main Methods:

• Immunohistochemical evaluation of IDO expression in nasal specimens.
• Study included healthy volunteers with and without birch pollen allergy, assessed both during and outside the pollen season.

Main Results:

• IDO expression levels were consistently low in both healthy controls and allergic rhinitis patients.
• No significant seasonal variations in IDO expression were observed in either group.

Conclusions:

• IDO appears associated with lower airway allergic inflammation but not upper airway inflammation in mild to moderate allergic rhinitis.
• The findings indicate a lack of a local role for IDO in the nasal cavity for these conditions.